Kyowa Hakko Kirin Value Stock - Dividend - Research Selection
Market price: 3.785,00 JPY
Kyowa Hakko Kirin Co., Ltd. Fundamental data and company key figures of the share
|Annual reports in JPY|
|Net operating cash flow||39.502.000.000|
|Free cash flow||4.275.000.064|
|Liabilities & Shareholders equity||801.290.000.000|
|Diluted shares outstanding||537.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||19.596.083.200,00 USD|
|Raw Data Source||IFRS in Millionen JPY|
Description of the company
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities. As of December 31, 2013, it had 47 subsidiaries, three associated companies and one parent company.